Last week, Strainprint, a leader in cannabis data and analytics, announced a partnership with Israeli research leaders, Lumir Lab and Gynica to conduct the world’s first international clinical study on the use of cannabis to treat endometriosis.

BofC’s Blaine Pearson caught up with Michelle Arbus, Strainprint’s VP of Research and Dr. Sari Prutchi Sagiv, Senior Scientist at Gynica to talk about the research.